Sponsored content – staggering results from Trial 21487PH

Prof.J.P.Haas

Home > Cardiology > ISTH 2020

Read the full Report (pdf)

International Society on Thrombosis and Haemostasis

12-14 July 2020

Featured articles

Letter from the Editor

Editor

Prof. Marc P. Bonaca, University of Colorado, USA

Conference

ISTH 2020

8 September, 2020 17:04

ISTH 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ISTH 2020

7 September, 2020 21:10

Online First

Haemophilia and Rare Bleeding Disorders

Novel gene therapy leads to normal FIX activity levels in severe haemophilia B

Presented By

Dr Pratima Chowdary, Royal Free London NHS Foundation Trust, United Kingdom

Trial

Phase 1/2, B-AMAZE

Conference

ISTH 2020

8 September, 2020 14:31

Haemophilia gene therapy: progress and obstacles

Presented By

Prof. Amit Nathwani, University College London, United Kingdom

Trial

Review study

Conference

ISTH 2020

8 September, 2020 14:27

Recombinant factor VIII safe and effective in PUPs A-LONG study

Presented By

Dr Christoph Königs, University Hospital Frankfurt, Germany

Trial

Phase 3, PUPs A-LONG

Conference

ISTH 2020

8 September, 2020 14:22

What’s New in Anticoagulation

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By

Prof. Renato D. Lopes, Duke University School of Medicine, USA

Trial

AUGUSTUS

Conference

ISTH 2020

8 September, 2020 14:59

Lower embryopathy risk with DOAC versus VKA during pregnancy

Presented By

Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany

Conference

ISTH 2020

8 September, 2020 14:53

Higher thrombotic risk in NSCLC patient with ALK rearrangement

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Conference

ISTH 2020

8 September, 2020 14:41

COVID-19 and Thrombosis

Crosstalk between inflammation and coagulation in severe COVID-19 infections

Presented By

Prof. Roberta Gualtierotti, University of Milan, Italy

Conference

ISTH 2020

8 September, 2020 15:21

COVID-19 associated with higher VTE rates relative to influenza

Presented By

Dr Milou Stals, Leiden University Medical Centre, the Netherlands

Conference

ISTH 2020

8 September, 2020 15:18

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Trial

Cohort study

Conference

ISTH 2020

8 September, 2020 15:15

COVID-19 not associated with heightened VTE risk after discharge

Presented By

Dr Matthias Engelen, University Hospital Leuven, Belgium

Conference

ISTH 2020

8 September, 2020 15:09

What’s New in Venous Thromboembolism

Residual pulmonary obstruction may predict risk of VTE recurrence

Presented By

Dr Robin Chaux, University Hospital St. Etienne, France

Conference

ISTH 2020

8 September, 2020 15:50

Less diagnostic delay in CTEPH diagnosis with novel algorithm

Presented By

Dr Gudula Boon, Leiden University Medical Center, the Netherlands

Trial

InSHAPE II

Conference

ISTH 2020

8 September, 2020 15:47

Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis

Presented By

Dr Florian Moik, Medical university of Vienna, Austria

Trial

Cohort study

Conference

ISTH 2020

8 September, 2020 15:44

Pearls of the Posters

Surgical bleeding risk most important determinant of bleeding outcomes

Presented By

Dr Kira MacDougall, Staten Island University Hospital, USA

Trial

PAUSE

Conference

ISTH 2020

8 September, 2020 16:27

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By

Dr Farès Moustafa, CHU Clermont Ferrand, France

Conference

ISTH 2020

8 September, 2020 16:21

Physical rehabilitation improves health outcomes after pulmonary embolism

Presented By

Dr Stephan Nopp, Medical University Vienna, Austria

Conference

ISTH 2020

8 September, 2020 16:18

Guidelines adherence reduces bleeding risk after surgery and childbirth for VWD patients

Presented By

Dr Brian Craven, Royal Free London NHS Foundation Trust, United Kingdom

Conference

ISTH 2020

8 September, 2020 16:15

Factor V Leiden mutation linked to atrial fibrillation

Presented By

Erin Mathiesen Hald, UiT The Arctic University of Norway, Tromsø, Norway

Trial

Cohort study, Tromsø Study

Conference

ISTH 2020

8 September, 2020 16:08

Increased rates of arterial thromboembolism in cancer patients

Presented By

Dr Frits Mulder, Amsterdam UMC, University of Amsterdam, the Netherlands

Conference

ISTH 2020

8 September, 2020 15:59

Medical Conferences

ISTH 2020

Featured articles

Letter from the Editor

ISTH 2020 Highlights Podcast

CONTENTS

Online First

Haemophilia and Rare Bleeding Disorders

Novel gene therapy leads to normal FIX activity levels in severe haemophilia B

Haemophilia gene therapy: progress and obstacles

Recombinant factor VIII safe and effective in PUPs A-LONG study

What’s New in Anticoagulation

Finding the sweet spot of anticoagulation in AF patients with ACS

Lower embryopathy risk with DOAC versus VKA during pregnancy

Higher thrombotic risk in NSCLC patient with ALK rearrangement

COVID-19 and Thrombosis

Crosstalk between inflammation and coagulation in severe COVID-19 infections

COVID-19 associated with higher VTE rates relative to influenza

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

COVID-19 not associated with heightened VTE risk after discharge

What’s New in Venous Thromboembolism

Residual pulmonary obstruction may predict risk of VTE recurrence

Less diagnostic delay in CTEPH diagnosis with novel algorithm

Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis

Pearls of the Posters

Surgical bleeding risk most important determinant of bleeding outcomes

Similar bleeding rates in patients with VTE and AF treated with DOACs

Physical rehabilitation improves health outcomes after pulmonary embolism

Guidelines adherence reduces bleeding risk after surgery and childbirth for VWD patients

Factor V Leiden mutation linked to atrial fibrillation

Increased rates of arterial thromboembolism in cancer patients